Complexity in KSR function revealed by Raf inhibitor and KSR structure studies

Area of Science:

• Cellular signaling pathways
• Cancer biology
• Molecular mechanisms of kinase regulation

Background:

• The Ras/Raf/MEK/ERK pathway is crucial for cell signaling and often dysregulated in human cancers.
• Kinase suppressor of Ras (KSR) is a key positive modulator of this pathway, functioning as a pseudokinase with scaffolding roles.
• Understanding KSR's precise function in normal and oncogenic Ras/ERK signaling is vital for cancer therapy.

Purpose of the Study:

• To elucidate the mechanistic details of KSR's regulation of MEK activation.
• To investigate the role of KSR in the context of Raf inhibitor efficacy in oncogenic Ras/ERK signaling.
• To explore the structural basis of KSR-mediated signaling.

Main Methods:

• Structural biology (KSR2/MEK1 complex structure determination).
• Analysis of KSR's scaffolding activities and interactions with Raf, MEK, and ERK.
• Investigation of KSR expression levels' impact on Raf inhibitor response.

Main Results:

• The KSR2/MEK1 structure reveals mechanisms of MEK activation and raises questions about KSR's intrinsic kinase activity.
• KSR proteins function as scaffolds, providing spatio-temporal regulation of ERK activation.
• KSR1 expression levels affect Raf inhibitor efficacy by competing with C-Raf for B-Raf binding, thereby attenuating paradoxical ERK activation.

Conclusions:

• KSR plays a critical role in spatio-temporal regulation of the Ras/ERK pathway through scaffolding.
• The structural insights into KSR2/MEK1 complex provide a mechanistic basis for KSR's function.
• KSR levels are a determinant of therapeutic response to Raf inhibitors in cancers driven by oncogenic Ras/ERK signaling.